Ya-Xin Zhu

Ya-Xin Zhu

Auto-generated profile, based on publicly available information

Ya-Xin Zhu

Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2015 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
SYShouliang Yin
Shouliang Yin
Weishan WangWeishan Wang
Weishan Wang
XWXuefeng Wang
Xuefeng Wang
YZYaxin Zhu
Yaxin Zhu
XJXiaole Jia
Xiaole Jia
KYKeqian Yang
Keqian Yang
Oxytetracycline (OTC) is a broad-spectrum antibiotic commercially produced by Streptomyces rimosus. Despite its importance, little is known about the regulation of OTC biosynthesis, which hampered any effort to improve OTC production via engineering regulatory genes. A gene encoding a Streptomyces antibiotic regulatory protein (SARP) was discovered immediately adjacent to the otrB gene of oxy cluster in S. rimosus and designated otcR. Deletion and complementation of otcR abolished or restored OTC production, respectively, indicating that otcR encodes an essential activator of OTC biosynthesis. Then, the predicted consensus SARP-binding sequences were extracted from the promoter regions of oxy cluster. Transcriptional analysis in a heterologous GFP reporter system demonstrated that OtcR directly activated the transcription of five oxy promoters in E. coli, further mutational analysis of a SARP-binding sequence of oxyI promoter proved that OtcR directly interacted with the consensus repeats. Therefore, otcR was chosen as an engineering target, OTC production was significantly increased by overexpression of otcR as tandem copies each under the control of strong SF14 promoter. A SARP activator, OtcR, was identified in oxy cluster of S. rimosus; it was shown to directly activate five promoters from oxy cluster. Overexpression of otcR at an appropriate level dramatically increased OTC production by 6.49 times compared to the parental strain, thus demonstrating the great potential of manipulating OtcR to improve the yield of OTC production.

20 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MWMeng-Ru Wu
Meng-Ru Wu
LMLili Miao
Lili Miao
YLYing Liu
Ying Liu
THTing-Ting Hou
Ting-Ting Hou
GAGuo-Min Ai
Guo-Min Ai
Shuang-Jiang LiuShuang-Jiang Liu
Shuang-Jiang Liu
Hydroxylamine is a key intermediate of microbial ammonia oxidation and plays an important role in the biogeochemical cycling of N-compounds. Hydroxylamine is oxidized to NO or N 2 O by hydroxylamine oxidases or cytochrome P460 from heterotrophic or autotrophic bacteria, but its enzymatic oxidation to N 2 has not yet been observed. Here, we report on the discovery of a novel oxidase that converts hydroxylamine to N 2 from the newly isolated heterotrophic nitrifier Alcaligenes strain HO-1. Strain HO-1 accumulated hydroxylamine and produced N 2 from ammonia oxidation. Using transcriptome analysis and heterologous expression via fosmid library screening, we identified three genes ( dnfABC ) of strain HO-1 that enabled E. coli cells not only to produce hydroxylamine from 15 N-labelled ammonium but also to further convert it to 15 N 2 . The three genes were individually cloned and expressed, and their translational products DnfA, DnfB, and DnfC were purified. In vitro DnfA bound to hydroxylamine and catalyzed the conversion of hydroxylamine to N 2 in the presence of FAD, NADH and O 2 . Thus, DnfA was identified as a novel hydroxylamine oxidase and catalyzed a previously unknown N-N bond forming reaction with a yet-to-be discovered mechanism. DnfA homologs were detected in different bacterial groups, suggesting that hydroxylamine oxidation to nitrogen might occur in additional microbial taxa.